Weifang Kanghua Biotechnology Co., Ltd's business scope: biological product technology development, technology transfer, technical consulting, technical services; the first, second and third types of medical devices, cosmetics, daily necessities, prepackaged food, disinfection supplies, agricultural and sideline products, feeds, electronic products; engage in the import and export business of goods or technology, etc..
The main business of Weifang Kanghua Biotechnology Co., Ltd. covers a wide range of fields such as clinical testing equipment, in vitro diagnostic reagents, medical electronics, etc., and it owns five platforms, namely, enzyme immunoassay, POCT, chemiluminescence, biochemical testing and molecular testing platform.
Weifang Kanghua Biotechnology Co., Ltd. has been honored as "National Contract and Credit Keeping Enterprise", "Advanced Taxpaying Enterprise", "China Patent Shandong Star Enterprise", etc. Its trademark has been recognized as the "China Patent Star Enterprise", and its trademark has been recognized as the "China Patent Star Enterprise". Ltd. has been awarded the honor of "State-level contract-abiding and credit-abiding enterprise", "Advanced tax-paying enterprise", "China Patent Shandong Star Enterprise" and so on.
On February 12, 2020, China Medical Equipment Association issued a notice: Weifang Kanghua Biotechnology Co., Ltd. was selected as one of the first batch of medical equipment urgently needed for the prevention and treatment of the new Crown pneumonia outbreak.